![]() |

![]() |
Create Name: | |
Description: |
![]() |
Save what matters to you |
{{ loginError }} |
Sign in with your RGD account |
Create New Account | Recover Password |
Analyze GeneStrainQTL List |
![]() Gene Annotator (Functional Annotation) unavailable |
![]() Gene Annotator (Annotation Distribution) unavailable |
![]() Variant Visualizer (Genomic Variants) unavailble Variant Visualizer (Genomic Variants) unavailable |
Gene Annotator (Functional Annotation) |
Gene Annotator (Annotation Distribution) |
Variant Visualizer (Genomic Variants) |
![]() InterViewer (Protein-Protein Interactions) unavailable |
![]() Gviewer (Genome Viewer) unavailable |
![]() Variant Visualizer (Damaging Variants) unavailble Variant Visualizer (Damaging Variants) unavailable |
InterViewer (Protein-Protein Interactions) |
GViewer (Genome Viewer) |
Variant Visualizer (Damaging Variants) |
![]() Gene Annotator (Annotation Comparison) unavailable |
![]() OLGA (Gene List Generator) unavailable |
![]() |
Gene Annotator (Annotation Comparison) |
OLGA (Gene List Generator) |
Excel (Download) |
![]() MOET (Multi-Ontology Enrichement) unavailable |
![]() GOLF (Gene-Ortholog Location Finder) unavailable |
|
MOET (Multi-Ontology Enrichement) |
GOLF (Gene-Ortholog Location Finder) |
![]() Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | ISO | RGD:727779 | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of NEK6 mRNA] | CTD | PMID:31150632 | (-)-epigallocatechin 3-gallate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of NEK6 mRNA | CTD | PMID:22079256 | 1,1-dichloroethene | increases expression | ISO | RGD:1551972 | 6480464 | vinylidene chloride results in increased expression of NEK6 mRNA | CTD | PMID:26682919 | 1-naphthyl isothiocyanate | increases expression | ISO | RGD:727779 | 6480464 | 1-Naphthylisothiocyanate results in increased expression of NEK6 mRNA | CTD | PMID:25380136 | 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:1551972 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NEK6 mRNA | CTD | PMID:17942748 | 17alpha-ethynylestradiol | increases expression | ISO | RGD:1551972 | 6480464 | Ethinyl Estradiol results in increased expression of NEK6 mRNA | CTD | PMID:17555576, PMID:17942748 | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with TGFB1 protein] results in increased expression of NEK6 mRNA | CTD | PMID:30165855 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1551972 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of NEK6 mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1551972 | 6480464 | Tetrachlorodibenzodioxin affects the expression of NEK6 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1551972 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NEK6 mRNA | CTD | PMID:17942748 | 2,4-dinitrotoluene | affects expression | ISO | RGD:727779 | 6480464 | 2, 4-dinitrotoluene affects the expression of NEK6 mRNA | CTD | PMID:21346803 | 2-acetamidofluorene | increases expression | ISO | RGD:727779 | 6480464 | 2-Acetylaminofluorene results in increased expression of NEK6 mRNA | CTD | PMID:22584684 | 4-amino-2,6-dinitrotoluene | affects expression | ISO | RGD:727779 | 6480464 | 4-amino-2, 6-dinitrotoluene affects the expression of NEK6 mRNA | CTD | PMID:21346803 | 4-hydroxynon-2-enal | decreases expression | ISO | RGD:1551972 | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of NEK6 mRNA | CTD | PMID:19191707 | 5-fluorouracil | decreases expression | EXP | | 6480464 | Fluorouracil results in decreased expression of NEK6 mRNA | CTD | PMID:17039268 | 6-propyl-2-thiouracil | decreases expression | ISO | RGD:727779 | 6480464 | Propylthiouracil results in decreased expression of NEK6 mRNA | CTD | PMID:18077114 | 6-propyl-2-thiouracil | increases expression | ISO | RGD:727779 | 6480464 | Propylthiouracil results in increased expression of NEK6 mRNA | CTD | PMID:24780913 | 8-bromo-3',5'-cyclic AMP | increases expression | EXP | | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of NEK6 mRNA | CTD | PMID:22079614 | aflatoxin B1 | increases methylation | EXP | | 6480464 | Aflatoxin B1 results in increased methylation of NEK6 gene | CTD | PMID:27153756 | aflatoxin B1 | affects methylation | EXP | | 6480464 | Aflatoxin B1 affects the methylation of NEK6 intron | CTD | PMID:30157460 | aflatoxin B2 | decreases methylation | EXP | | 6480464 | aflatoxin B2 results in decreased methylation of NEK6 promoter | CTD | PMID:30157460 | antirheumatic drug | decreases expression | EXP | | 6480464 | Antirheumatic Agents results in decreased expression of NEK6 mRNA | CTD | PMID:24449571 | Aroclor 1254 | increases expression | EXP | | 6480464 | Chlorodiphenyl (54% Chlorine) results in increased expression of NEK6 mRNA | CTD | PMID:16934159 | benzo[a]pyrene | multiple interactions | ISO | RGD:1551972 | 6480464 | Benzo(a)pyrene promotes the reaction [AHR protein binds to NEK6 promoter] | CTD | PMID:19654925 | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of NEK6 promoter | CTD | PMID:30157460 | benzo[a]pyrene | decreases expression | ISO | RGD:1551972 | 6480464 | Benzo(a)pyrene results in decreased expression of NEK6 mRNA | CTD | PMID:19770486 | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of NEK6 mRNA | CTD | PMID:20064835 | benzo[a]pyrene diol epoxide I | decreases expression | EXP | | 6480464 | 7 more ... | CTD | PMID:19150397 | bisphenol A | affects expression | ISO | RGD:727779 | 6480464 | bisphenol A affects the expression of NEK6 mRNA | CTD | PMID:25181051 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of NEK6 mRNA | CTD | PMID:29275510 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of NEK6 mRNA | CTD | PMID:30903817 | carbamazepine | affects expression | EXP | | 6480464 | Carbamazepine affects the expression of NEK6 mRNA | CTD | PMID:25979313 | carbon nanotube | increases expression | ISO | RGD:1551972 | 6480464 | Nanotubes, Carbon analog results in increased expression of NEK6 mRNA, Nanotubes, Carbon results in increased expression of NEK6 mRNA | CTD | PMID:25554681, PMID:25620056 | carmustine | increases expression | ISO | RGD:727779 | 6480464 | Carmustine results in increased expression of NEK6 mRNA | CTD | PMID:16005536 | cefaloridine | increases expression | ISO | RGD:727779 | 6480464 | Cephaloridine results in increased expression of NEK6 mRNA | CTD | PMID:18500788 | cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of NEK6 mRNA | CTD | PMID:19320972 | cobalt dichloride | decreases expression | ISO | RGD:727779 | 6480464 | cobaltous chloride results in decreased expression of NEK6 mRNA | CTD | PMID:24386269 | copper atom | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of NEK6 mRNA | CTD | PMID:20971185 | copper(0) | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of NEK6 mRNA | CTD | PMID:20971185 | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of NEK6 mRNA | CTD | PMID:20106945, PMID:25562108 | diclofenac | increases expression | ISO | RGD:1551972 | 6480464 | Diclofenac results in increased expression of NEK6 mRNA | CTD | PMID:26934552 | dioxygen | multiple interactions | ISO | RGD:1551972 | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NEK6 mRNA | CTD | PMID:30529165 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NEK6 mRNA | CTD | PMID:27188386 | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of NEK6 mRNA | CTD | PMID:29803840 | fenamidone | increases expression | ISO | RGD:1551972 | 6480464 | fenamidone results in increased expression of NEK6 mRNA | CTD | PMID:27029645 | glafenine | increases expression | ISO | RGD:727779 | 6480464 | Glafenine results in increased expression of NEK6 mRNA | CTD | PMID:24136188 | lead(0) | affects expression | EXP | | 6480464 | Lead affects the expression of NEK6 mRNA | CTD | PMID:28903495 | lead(2+) | affects expression | EXP | | 6480464 | Lead affects the expression of NEK6 mRNA | CTD | PMID:28903495 | leflunomide | increases expression | ISO | RGD:727779 | 6480464 | leflunomide results in increased expression of NEK6 mRNA | CTD | PMID:24136188 | methotrexate | increases expression | ISO | RGD:727779 | 6480464 | Methotrexate results in increased expression of NEK6 mRNA | CTD | PMID:16005536 | methyl methanesulfonate | decreases expression | EXP | | 6480464 | Methyl Methanesulfonate results in decreased expression of NEK6 mRNA | CTD | PMID:23649840 | methylmercury chloride | increases expression | EXP | | 6480464 | methylmercuric chloride results in increased expression of NEK6 mRNA | CTD | PMID:28001369 | N-nitrosodiethylamine | increases expression | ISO | RGD:727779 | 6480464 | Diethylnitrosamine results in increased expression of NEK6 mRNA | CTD | PMID:19638242 | N-nitrosodimethylamine | increases expression | ISO | RGD:727779 | 6480464 | Dimethylnitrosamine results in increased expression of NEK6 mRNA | CTD | PMID:25380136 | nickel atom | increases expression | EXP | | 6480464 | Nickel results in increased expression of NEK6 mRNA | CTD | PMID:25583101 | oxaliplatin | multiple interactions | ISO | RGD:727779 | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of NEK6 mRNA | CTD | PMID:25729387 | paracetamol | affects expression | ISO | RGD:1551972 | 6480464 | Acetaminophen affects the expression of NEK6 mRNA | CTD | PMID:17562736 | phenylmercury acetate | increases expression | EXP | | 6480464 | Phenylmercuric Acetate results in increased expression of NEK6 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NEK6 mRNA | CTD | PMID:27188386 | pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of NEK6 mRNA | CTD | PMID:19710929 | pirinixic acid | decreases expression | ISO | RGD:1551972 | 6480464 | pirinixic acid results in decreased expression of NEK6 mRNA | CTD | PMID:17426115 | potassium chromate | decreases expression | EXP | | 6480464 | potassium chromate(VI) results in decreased expression of NEK6 mRNA | CTD | PMID:22079256 | potassium chromate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of NEK6 mRNA | CTD | PMID:22079256 | propiconazole | increases expression | ISO | RGD:1551972 | 6480464 | propiconazole results in increased expression of NEK6 mRNA | CTD | PMID:21278054 | protein kinase inhibitor | multiple interactions | EXP | | 6480464 | Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of NEK6 mRNA] | CTD | PMID:28003376 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NEK6 mRNA | CTD | PMID:27188386 | silicon dioxide | increases expression | EXP | | 6480464 | Silicon Dioxide analog results in increased expression of NEK6 mRNA | CTD | PMID:25895662 | silicon dioxide | increases expression | ISO | RGD:1551972 | 6480464 | Silicon Dioxide results in increased expression of NEK6 mRNA | CTD | PMID:23221170, PMID:29203145 | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of NEK6 mRNA | CTD | PMID:12016162 | sodium dichromate | increases expression | ISO | RGD:727779 | 6480464 | sodium bichromate results in increased expression of NEK6 mRNA | CTD | PMID:25993096 | Soman | increases expression | ISO | RGD:727779 | 6480464 | Soman results in increased expression of NEK6 mRNA | CTD | PMID:19281266 | tamoxifen | affects expression | ISO | RGD:1551972 | 6480464 | Tamoxifen affects the expression of NEK6 mRNA | CTD | PMID:17555576 | tetrachloromethane | increases expression | ISO | RGD:1551972 | 6480464 | Carbon Tetrachloride results in increased expression of NEK6 mRNA | CTD | PMID:27339419 | tetrachloromethane | increases expression | ISO | RGD:727779 | 6480464 | Carbon Tetrachloride results in increased expression of NEK6 mRNA | CTD | PMID:31150632 | tetrachloromethane | multiple interactions | ISO | RGD:727779 | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of NEK6 mRNA] | CTD | PMID:31150632 | thioacetamide | increases expression | ISO | RGD:727779 | 6480464 | Thioacetamide results in increased expression of NEK6 mRNA | CTD | PMID:23411599 | tioguanine | increases expression | ISO | RGD:727779 | 6480464 | Thioguanine results in increased expression of NEK6 mRNA | CTD | PMID:16005536 | titanium dioxide | increases expression | ISO | RGD:1551972 | 6480464 | titanium dioxide results in increased expression of NEK6 mRNA | CTD | PMID:23557971, PMID:27760801 | topotecan | multiple interactions | ISO | RGD:727779 | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of NEK6 mRNA | CTD | PMID:25729387 | tunicamycin | decreases expression | EXP | | 6480464 | Tunicamycin results in decreased expression of NEK6 mRNA | CTD | PMID:22378314 | urethane | decreases expression | EXP | | 6480464 | Urethane results in decreased expression of NEK6 mRNA | CTD | PMID:28818685 | valproic acid | affects expression | ISO | RGD:1551972 | 6480464 | Valproic Acid affects the expression of NEK6 mRNA | CTD | PMID:17292431 | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of NEK6 mRNA | CTD | PMID:25979313 | valproic acid | decreases methylation | EXP | | 6480464 | Valproic Acid results in decreased methylation of NEK6 gene | CTD | PMID:29154799 | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of NEK6 mRNA | CTD | PMID:23179753, PMID:29154799 | vinclozolin | decreases expression | ISO | RGD:727779 | 6480464 | vinclozolin results in decreased expression of NEK6 mRNA | CTD | PMID:23034163 | zinc atom | multiple interactions | EXP | | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of NEK6 mRNA | CTD | PMID:18593933 | zinc(0) | multiple interactions | EXP | | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of NEK6 mRNA | CTD | PMID:18593933 | |
|
|
|
|
|
|
|
|
|
|
|
1. | GOA_HUMAN data from the GO Consortium |
2. | RGD automated import pipeline for gene-chemical interactions |
PubMed | 10191262 10702691 10964517 11516946 11701951 12023960 12054534 12101123 12477932 12761501 12840024 14563848 15342556 15489334 15761153 16189514 16280549 16344560 16476580 17353931 17512906 18728393 19001501 19414596 20125193 20379614 20595392 20677014 20873783 21099361 21200151 21320329 21454704 21539811 21642957 21725899 21988832 22305495 22939629 23416273 24763737 25416956 25523445 25940345 26186194 26259750 26423403 27396482 27637333 27899381 28329684 28514442 28611215 28630147 28720575 30153958 30207869 |
NEK6 (Homo sapiens - human) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nek6 (Mus musculus - house mouse) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nek6 (Rattus norvegicus - Norway rat) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nek6 (Chinchilla lanigera - long-tailed chinchilla) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NEK6 (Pan paniscus - bonobo/pygmy chimpanzee) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NEK6 (Canis lupus familiaris - dog) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nek6 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NEK6 (Sus scrofa - pig) |
|
RH77983 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
SGC33089 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
RH119892 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
SHGC-154753 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
RH11482 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
RH11599 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
RH12239 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
G20648 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
A006A17 |
|
The detailed report is available here: | ![]() | Full Report | ![]() | CSV | ![]() | TAB | ![]() | Printer |
miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/). For more information about miRGate, see PMID:25858286 or access the full paper here. |
RefSeq Transcripts | NM_001145001 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles |
NM_001166167 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
NM_001166168 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
NM_001166169 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
NM_001166170 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
NM_001166171 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
NM_014397 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
XM_005251664 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
XM_006716936 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
XM_017014217 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
XM_024447385 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
XM_024447386 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
XM_024447387 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
GenBank Nucleotide | AB026289 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles |
AF087909 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AJ420460 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AK294614 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AK313071 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AL137846 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AL162724 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
BC000101 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
BC004174 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
BC004209 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
BC012761 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
BM083872 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
BP219389 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
BP265230 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
BP279761 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
CF994196 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
CH471090 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
CR457091 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
CR542222 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
DB350175 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
KT584908 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles |
RefSeq Acc Id: | NM_001145001 ⟹ NP_001138473 | ||||||||||||||||||||||||
RefSeq Status: | REVIEWED | ||||||||||||||||||||||||
Type: | CODING | ||||||||||||||||||||||||
Position: |
|
||||||||||||||||||||||||
Sequence: |
GGGCGGGCGCGCGGGCGCGCGGGCCCGCGCAGGCGGTGGCGGCGGCGGCGGAACCGAGCTGACGhide sequence |
RefSeq Acc Id: | NM_001166167 ⟹ NP_001159639 | ||||||||||||||||||||||||
RefSeq Status: | REVIEWED | ||||||||||||||||||||||||
Type: | CODING | ||||||||||||||||||||||||
Position: |
|
||||||||||||||||||||||||
Sequence: |
GCAATGCTAGGCGATGGGGAATCCGAAGACGCACAGGAGTCCAAGGGTTGGCTGACTGCAGACChide sequence |
RefSeq Acc Id: | NM_001166168 ⟹ NP_001159640 | ||||||||||||||||||||||||
RefSeq Status: | REVIEWED | ||||||||||||||||||||||||
Type: | CODING | ||||||||||||||||||||||||
Position: |
|
||||||||||||||||||||||||
Sequence: |
GAGCGTGTCGGCGGCCGGGCGGGCGGGGGCGGCGTGTCCGCGTGTCCCGGGGTGTGCGCGTCCChide sequence |
RefSeq Acc Id: | NM_001166169 ⟹ NP_001159641 | ||||||||||||||||||||||||
RefSeq Status: | REVIEWED | ||||||||||||||||||||||||
Type: | CODING | ||||||||||||||||||||||||
Position: |
|
||||||||||||||||||||||||
Sequence: |
TTTTGTCTGCCCCTTCCTGCCTGTGGGAAGGAGAGAAAATTAGGGGAGGCCACGGGCTTGAAAGhide sequence |
RefSeq Acc Id: | NM_001166170 ⟹ NP_001159642 | ||||||||||||||||||||||||
RefSeq Status: | REVIEWED | ||||||||||||||||||||||||
Type: | CODING | ||||||||||||||||||||||||
Position: |
|
||||||||||||||||||||||||
Sequence: |
CACCCACCCCAGCCCAGAGAGGCGACCCAGCTCCCTGGAGGCCCAGGCACCTCATGTCTGCCCThide sequence |
RefSeq Acc Id: | NM_001166171 ⟹ NP_001159643 | ||||||||||||||||||||||||
RefSeq Status: | REVIEWED | ||||||||||||||||||||||||
Type: | CODING | ||||||||||||||||||||||||
Position: |
|
||||||||||||||||||||||||
Sequence: |
CACCCACCCCAGCCCAGAGAGGCGACCCAGCTCCCTGGAGGCCCAGGCACCTCATGTCTGCCCThide sequence |
RefSeq Acc Id: | NM_014397 ⟹ NP_055212 | |||||||||||||||||||||||||||||
RefSeq Status: | REVIEWED | |||||||||||||||||||||||||||||
Type: | CODING | |||||||||||||||||||||||||||||
Position: |
|
|||||||||||||||||||||||||||||
Sequence: |
GGGCGGGCGCGCGGGCGCGCGGGCCCGCGCAGGCGGTGGCGGCGGCGGCGGAACCGAGCTGACGhide sequence |
RefSeq Acc Id: | XM_005251664 ⟹ XP_005251721 | ||||||||||||||
RefSeq Status: | |||||||||||||||
Type: | CODING | ||||||||||||||
Position: |
|
||||||||||||||
Sequence: |
AGTGGAGGGACCTGGTGAATCATCCAAGATTAAATACGGGCAGGCACTGCCAGGCTTGTGTGGAhide sequence |
RefSeq Acc Id: | XM_006716936 ⟹ XP_006716999 | |||||||||
RefSeq Status: | ||||||||||
Type: | CODING | |||||||||
Position: |
|
|||||||||
Sequence: |
GGAGGTGGCCCCACCTGCCAGTCTGTGATTGCCACAGAGACAAGCCAGCCAAGAAGTGCCACCChide sequence |
RefSeq Acc Id: | XM_017014217 ⟹ XP_016869706 | |||||||||
RefSeq Status: | ||||||||||
Type: | CODING | |||||||||
Position: |
|
|||||||||
Sequence: |
AGGTGGCCCCACCTGCCAGTCTGTGATTGCCACAGAGACAAGCCAGCCAAGAAGTGCCACCCTGhide sequence |
RefSeq Acc Id: | XM_024447385 ⟹ XP_024303153 | |||||||||
RefSeq Status: | ||||||||||
Type: | CODING | |||||||||
Position: |
|
|||||||||
Sequence: |
AATAAATAAACAAACAGCAAGAACAGTTATGCTTTTCAGCATTTTGCTGGGCCCCAGTGTGGAThide sequence |
RefSeq Acc Id: | XM_024447386 ⟹ XP_024303154 | |||||||||
RefSeq Status: | ||||||||||
Type: | CODING | |||||||||
Position: |
|
|||||||||
Sequence: |
GGAGATGAGGCTGGGACACTGTTCGCAGGAAGAGTCCGGTGTTCTGGCCCCCTGATGTCACCTThide sequence |
RefSeq Acc Id: | XM_024447387 ⟹ XP_024303155 | |||||||||
RefSeq Status: | ||||||||||
Type: | CODING | |||||||||
Position: |
|
|||||||||
Sequence: |
ACCCCGGAGCGTCTGGTGGCGTTGTTGGGGGAGGTGGCCCCACCTGCCAGTCTGTGATTGCCAChide sequence |
Protein RefSeqs | NP_001138473 | (Get FASTA) | NCBI Sequence Viewer |
NP_001159639 | (Get FASTA) | NCBI Sequence Viewer | |
NP_001159640 | (Get FASTA) | NCBI Sequence Viewer | |
NP_001159641 | (Get FASTA) | NCBI Sequence Viewer | |
NP_001159642 | (Get FASTA) | NCBI Sequence Viewer | |
NP_001159643 | (Get FASTA) | NCBI Sequence Viewer | |
NP_055212 | (Get FASTA) | NCBI Sequence Viewer | |
XP_005251721 | (Get FASTA) | NCBI Sequence Viewer | |
XP_006716999 | (Get FASTA) | NCBI Sequence Viewer | |
XP_016869706 | (Get FASTA) | NCBI Sequence Viewer | |
XP_024303153 | (Get FASTA) | NCBI Sequence Viewer | |
XP_024303154 | (Get FASTA) | NCBI Sequence Viewer | |
XP_024303155 | (Get FASTA) | NCBI Sequence Viewer | |
GenBank Protein | AAG13417 | (Get FASTA) | NCBI Sequence Viewer |
AAH00101 | (Get FASTA) | NCBI Sequence Viewer | |
AAH04174 | (Get FASTA) | NCBI Sequence Viewer | |
AAH04209 | (Get FASTA) | NCBI Sequence Viewer | |
AAH12761 | (Get FASTA) | NCBI Sequence Viewer | |
BAA85045 | (Get FASTA) | NCBI Sequence Viewer | |
BAG35899 | (Get FASTA) | NCBI Sequence Viewer | |
BAH11825 | (Get FASTA) | NCBI Sequence Viewer | |
CAG33372 | (Get FASTA) | NCBI Sequence Viewer | |
CAG47018 | (Get FASTA) | NCBI Sequence Viewer | |
EAW87578 | (Get FASTA) | NCBI Sequence Viewer | |
EAW87579 | (Get FASTA) | NCBI Sequence Viewer | |
EAW87580 | (Get FASTA) | NCBI Sequence Viewer | |
EAW87581 | (Get FASTA) | NCBI Sequence Viewer | |
Q9HC98 | (Get FASTA) | NCBI Sequence Viewer |
RefSeq Acc Id: | NP_001138473 ⟸ NM_001145001 |
- Peptide Label: | isoform 1 |
- UniProtKB: | Q9HC98 (UniProtKB/Swiss-Prot) |
- Sequence: |
MPRREVCWEAAHFRQEEQSLPRPRVRALVRLACRMAGQPGHMPHGGSSNNLCHTLGPVHPPDPQhide sequence |
RefSeq Acc Id: | NP_055212 ⟸ NM_014397 |
- Peptide Label: | isoform 2 |
- UniProtKB: | Q9HC98 (UniProtKB/Swiss-Prot), A0A024R8A6 (UniProtKB/TrEMBL) |
- Sequence: |
MAGQPGHMPHGGSSNNLCHTLGPVHPPDPQRHPNTLSFRCSLADFQIEKKIGRGQFSEVYKATChide sequence |
RefSeq Acc Id: | NP_001159640 ⟸ NM_001166168 |
- Peptide Label: | isoform 2 |
- UniProtKB: | Q9HC98 (UniProtKB/Swiss-Prot), A0A024R8A6 (UniProtKB/TrEMBL) |
- Sequence: |
MAGQPGHMPHGGSSNNLCHTLGPVHPPDPQRHPNTLSFRCSLADFQIEKKIGRGQFSEVYKATChide sequence |
RefSeq Acc Id: | NP_001159643 ⟸ NM_001166171 |
- Peptide Label: | isoform 1 |
- UniProtKB: | Q9HC98 (UniProtKB/Swiss-Prot) |
- Sequence: |
MPRREVCWEAAHFRQEEQSLPRPRVRALVRLACRMAGQPGHMPHGGSSNNLCHTLGPVHPPDPQhide sequence |
RefSeq Acc Id: | NP_001159642 ⟸ NM_001166170 |
- Peptide Label: | isoform 2 |
- UniProtKB: | Q9HC98 (UniProtKB/Swiss-Prot), A0A024R8A6 (UniProtKB/TrEMBL) |
- Sequence: |
MAGQPGHMPHGGSSNNLCHTLGPVHPPDPQRHPNTLSFRCSLADFQIEKKIGRGQFSEVYKATChide sequence |
RefSeq Acc Id: | NP_001159641 ⟸ NM_001166169 |
- Peptide Label: | isoform 4 |
- UniProtKB: | Q9HC98 (UniProtKB/Swiss-Prot) |
- Sequence: |
MEATGWDSRCSPGTQVRALVRLACRMAGQPGHMPHGGSSNNLCHTLGPVHPPDPQRHPNTLSFRhide sequence |
RefSeq Acc Id: | NP_001159639 ⟸ NM_001166167 |
- Peptide Label: | isoform 3 |
- UniProtKB: | Q9HC98 (UniProtKB/Swiss-Prot) |
- Sequence: |
MGRRRPAPFRALVRLACRMAGQPGHMPHGGSSNNLCHTLGPVHPPDPQRHPNTLSFRCSLADFQhide sequence |
RefSeq Acc Id: | XP_005251721 ⟸ XM_005251664 |
- Peptide Label: | isoform X3 |
- UniProtKB: | Q9HC98 (UniProtKB/Swiss-Prot), A0A024R8A6 (UniProtKB/TrEMBL) |
- Sequence: |
MAGQPGHMPHGGSSNNLCHTLGPVHPPDPQRHPNTLSFRCSLADFQIEKKIGRGQFSEVYKATChide sequence |
RefSeq Acc Id: | XP_006716999 ⟸ XM_006716936 |
- Peptide Label: | isoform X3 |
- UniProtKB: | Q9HC98 (UniProtKB/Swiss-Prot), A0A024R8A6 (UniProtKB/TrEMBL) |
- Sequence: |
MAGQPGHMPHGGSSNNLCHTLGPVHPPDPQRHPNTLSFRCSLADFQIEKKIGRGQFSEVYKATChide sequence |
RefSeq Acc Id: | XP_016869706 ⟸ XM_017014217 |
- Peptide Label: | isoform X2 |
- UniProtKB: | Q9HC98 (UniProtKB/Swiss-Prot) |
- Sequence: |
MPRREVCWEAAHFRQEEQSLPRPRVRALVRLACRMAGQPGHMPHGGSSNNLCHTLGPVHPPDPQhide sequence |
RefSeq Acc Id: | XP_024303155 ⟸ XM_024447387 |
- Peptide Label: | isoform X3 |
- Sequence: |
MAGQPGHMPHGGSSNNLCHTLGPVHPPDPQRHPNTLSFRCSLADFQIEKKIGRGQFSEVYKATChide sequence |
RefSeq Acc Id: | XP_024303154 ⟸ XM_024447386 |
- Peptide Label: | isoform X3 |
- Sequence: |
MAGQPGHMPHGGSSNNLCHTLGPVHPPDPQRHPNTLSFRCSLADFQIEKKIGRGQFSEVYKATChide sequence |
RefSeq Acc Id: | XP_024303153 ⟸ XM_024447385 |
- Peptide Label: | isoform X1 |
- Sequence: |
MRRQRPFFLHPPQPREATQLPGGPGTSCLPSTQSGADLPWSFSGATSKVRALVRLACRMAGQPGhide sequence |
RGD ID: | 7216107 | |||||||||
Promoter ID: | EPDNEW_H13800 | |||||||||
Type: | initiation region | |||||||||
Name: | NEK6_3 | |||||||||
Description: | NIMA related kinase 6 | |||||||||
SO ACC ID: | SO:0000170 | |||||||||
Source: | EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/) | |||||||||
Experiment Methods: | Single-end sequencing. | |||||||||
Position: |
|
RGD ID: | 7216109 | |||||||||
Promoter ID: | EPDNEW_H13801 | |||||||||
Type: | initiation region | |||||||||
Name: | NEK6_1 | |||||||||
Description: | NIMA related kinase 6 | |||||||||
SO ACC ID: | SO:0000170 | |||||||||
Source: | EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/) | |||||||||
Experiment Methods: | Single-end sequencing. | |||||||||
Position: |
|
RGD ID: | 7216111 | |||||||||
Promoter ID: | EPDNEW_H13802 | |||||||||
Type: | initiation region | |||||||||
Name: | NEK6_2 | |||||||||
Description: | NIMA related kinase 6 | |||||||||
SO ACC ID: | SO:0000170 | |||||||||
Source: | EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/) | |||||||||
Experiment Methods: | Single-end sequencing. | |||||||||
Position: |
|
RGD ID: | 6807504 | |||||||||
Promoter ID: | HG_KWN:64878 | |||||||||
Type: | CpG-Island | |||||||||
SO ACC ID: | SO:0000170 | |||||||||
Source: | MPROMDB | |||||||||
Tissues & Cell Lines: | K562, Lymphoblastoid, NB4 | |||||||||
Transcripts: | ENST00000373600, ENST00000373601, ENST00000373603, OTTHUMT00000054016, OTTHUMT00000054019, OTTHUMT00000054020, UC010MWJ.1, UC010MWK.1 | |||||||||
Position: |
|
RGD ID: | 6807513 | |||||||||
Promoter ID: | HG_KWN:64879 | |||||||||
Type: | Non-CpG | |||||||||
SO ACC ID: | SO:0000170 | |||||||||
Source: | MPROMDB | |||||||||
Tissues & Cell Lines: | HeLa_S3, K562, Lymphoblastoid | |||||||||
Transcripts: | ENST00000373596, OTTHUMT00000054013, OTTHUMT00000054022 | |||||||||
Position: |
|
RGD ID: | 6807904 | |||||||||
Promoter ID: | HG_KWN:64882 | |||||||||
Type: | CpG-Island | |||||||||
SO ACC ID: | SO:0000170 | |||||||||
Source: | MPROMDB | |||||||||
Tissues & Cell Lines: | CD4+TCell, K562, Lymphoblastoid | |||||||||
Transcripts: | OTTHUMT00000054023 | |||||||||
Position: |
|
RGD ID: | 6807507 | |||||||||
Promoter ID: | HG_KWN:64883 | |||||||||
Type: | Non-CpG | |||||||||
SO ACC ID: | SO:0000170 | |||||||||
Source: | MPROMDB | |||||||||
Tissues & Cell Lines: | CD4+TCell, K562, Lymphoblastoid, NB4 | |||||||||
Transcripts: | ENST00000394199, NM_001166169, NM_001166171, OTTHUMT00000054015, UC004BOI.1 | |||||||||
Position: |
|
RGD ID: | 6807906 | |||||||||
Promoter ID: | HG_KWN:64884 | |||||||||
Type: | Non-CpG | |||||||||
SO ACC ID: | SO:0000170 | |||||||||
Source: | MPROMDB | |||||||||
Tissues & Cell Lines: | K562, Lymphoblastoid | |||||||||
Transcripts: | OTTHUMT00000054024 | |||||||||
Position: |
|
RGD ID: | 6814814 | |||||||||
Promoter ID: | HG_XEF:8400 | |||||||||
Type: | Non-CpG | |||||||||
SO ACC ID: | SO:0000170 | |||||||||
Source: | MPROMDB | |||||||||
Tissues & Cell Lines: | Lymphoblastoid | |||||||||
Transcripts: | NM_001159631, NM_182953 | |||||||||
Position: |
|
RGD ID: | 6814815 | |||||||||
Promoter ID: | HG_XEF:8401 | |||||||||
Type: | Non-CpG | |||||||||
SO ACC ID: | SO:0000170 | |||||||||
Source: | MPROMDB | |||||||||
Tissues & Cell Lines: | Lymphoblastoid | |||||||||
Transcripts: | NM_001006699, NM_001012531, NM_001087185, NM_001097145, NM_001141414 | |||||||||
Position: |
|
Name | Type | Condition(s) | Position(s) | Clinical significance |
GRCh38/hg38 9p24.3-q34.3(chr9:193412-138179445)x3 | copy number gain | Global developmental delay [RCV000050347]|Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000050348]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000050348]|See cases [RCV000050348] | Chr9:193412..138179445 [GRCh38] Chr9:204193..141073897 [GRCh37] Chr9:194193..140193718 [NCBI36] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh38/hg38 9q33.2-34.3(chr9:122792658-138124532)x3 | copy number gain | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051040]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051040]|See cases [RCV000051040] | Chr9:122792658..138124532 [GRCh38] Chr9:125554937..141018984 [GRCh37] Chr9:124594758..140138805 [NCBI36] Chr9:9q33.2-34.3 |
pathogenic |
GRCh38/hg38 9q33.2-34.3(chr9:121112395-138075224)x3 | copy number gain | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051009]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051009]|See cases [RCV000051009] | Chr9:121112395..138075224 [GRCh38] Chr9:123874673..140969676 [GRCh37] Chr9:122914494..140089497 [NCBI36] Chr9:9q33.2-34.3 |
pathogenic |
GRCh38/hg38 9p24.3-q34.3(chr9:193412-138124532)x3 | copy number gain | Intrauterine growth retardation [RCV000053745]|See cases [RCV000053745] | Chr9:193412..138124532 [GRCh38] Chr9:204193..141018984 [GRCh37] Chr9:194193..140138805 [NCBI36] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh38/hg38 9p24.3-q34.3(chr9:193412-138114463)x3 | copy number gain | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053746]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053746]|See cases [RCV000053746] | Chr9:193412..138114463 [GRCh38] Chr9:214367..141008915 [GRCh37] Chr9:204367..140128736 [NCBI36] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh38/hg38 9p24.3-q34.3(chr9:193412-138179445)x3 | copy number gain | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053748]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053748]|See cases [RCV000053748] | Chr9:193412..138179445 [GRCh38] Chr9:266045..141073897 [GRCh37] Chr9:256045..140193718 [NCBI36] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh38/hg38 9q33.2-34.3(chr9:121586837-138179445)x3 | copy number gain | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053776]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053776]|See cases [RCV000053776] | Chr9:121586837..138179445 [GRCh38] Chr9:124349116..141073897 [GRCh37] Chr9:123388937..140193718 [NCBI36] Chr9:9q33.2-34.3 |
pathogenic |
GRCh38/hg38 9p24.3-q34.3(chr9:204193-138179445) | copy number gain | See cases [RCV000133791] | Chr9:204193..138179445 [GRCh38] Chr9:204193..141073897 [GRCh37] Chr9:194193..140193718 [NCBI36] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh38/hg38 9q33.2-34.3(chr9:121073102-138179445)x3 | copy number gain | See cases [RCV000134920] | Chr9:121073102..138179445 [GRCh38] Chr9:123835380..141073897 [GRCh37] Chr9:122875201..140193718 [NCBI36] Chr9:9q33.2-34.3 |
pathogenic |
GRCh38/hg38 9p24.3-q34.3(chr9:193412-138124524)x3 | copy number gain | See cases [RCV000138783] | Chr9:193412..138124524 [GRCh38] Chr9:204090..141018976 [GRCh37] Chr9:194090..140138797 [NCBI36] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh38/hg38 9p11.2-q34.3(chr9:193412-138159073)x3 | copy number gain | See cases [RCV000139207] | Chr9:193412..138159073 [GRCh38] Chr9:68420641..141053525 [GRCh37] Chr9:67910461..140173346 [NCBI36] Chr9:9p11.2-q34.3 |
pathogenic |
GRCh38/hg38 9p24.3-q34.3(chr9:193412-138159073)x3 | copy number gain | See cases [RCV000138962] | Chr9:193412..138159073 [GRCh38] Chr9:204104..141053525 [GRCh37] Chr9:194104..140173346 [NCBI36] Chr9:9p24.3-q34.3 |
pathogenic|conflicting data from submitters |
GRCh38/hg38 9p24.3-q34.3(chr9:203861-138125937)x3 | copy number gain | See cases [RCV000141876] | Chr9:203861..138125937 [GRCh38] Chr9:203861..141020389 [GRCh37] Chr9:193861..140140210 [NCBI36] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh38/hg38 9q33.2-33.3(chr9:123095598-126693843)x1 | copy number loss | See cases [RCV000141589] | Chr9:123095598..126693843 [GRCh38] Chr9:125857877..129456122 [GRCh37] Chr9:124897698..128495943 [NCBI36] Chr9:9q33.2-33.3 |
pathogenic |
GRCh38/hg38 9p24.3-q34.3(chr9:203862-138125937)x3 | copy number gain | See cases [RCV000143476] | Chr9:203862..138125937 [GRCh38] Chr9:203862..141020389 [GRCh37] Chr9:193862..140140210 [NCBI36] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh38/hg38 9p24.3-q34.3(chr9:193412-138179445)x3 | copy number gain | See cases [RCV000148113] | Chr9:193412..138179445 [GRCh38] Chr9:204193..141073897 [GRCh37] Chr9:194193..140193718 [NCBI36] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh37/hg19 9p24.3-q34.3(chr9:163131-141122114)x3 | copy number gain | See cases [RCV000240081] | Chr9:163131..141122114 [GRCh37] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh37/hg19 9q21.11-34.3(chr9:71069743-140999928) | copy number gain | Global developmental delay [RCV000626548]|Seizures [RCV000626548] | Chr9:71069743..140999928 [GRCh37] Chr9:9q21.11-34.3 |
likely pathogenic |
GRCh37/hg19 9p24.3-q34.3(chr9:62525-141006407) | copy number gain | See cases [RCV000449375] | Chr9:62525..141006407 [GRCh37] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh37/hg19 9p24.3-q34.3(chr9:203861-141020389)x3 | copy number gain | See cases [RCV000447207] | Chr9:203861..141020389 [GRCh37] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh37/hg19 9p24.3-q34.3(chr9:203864-141020389)x3 | copy number gain | See cases [RCV000448978] | Chr9:203864..141020389 [GRCh37] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh37/hg19 9q33.2-34.3(chr9:124642754-141146461)x3 | copy number gain | See cases [RCV000448784] | Chr9:124642754..141146461 [GRCh37] Chr9:9q33.2-34.3 |
pathogenic |
GRCh37/hg19 9p24.3-q34.3(chr9:203862-141020389) | copy number gain | See cases [RCV000512392] | Chr9:203862..141020389 [GRCh37] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh37/hg19 9p24.3-q34.3(chr9:10590-141122247)x3 | copy number gain | not provided [RCV000748055] | Chr9:10590..141122247 [GRCh37] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh37/hg19 9p24.3-q34.3(chr9:10590-141107672)x3 | copy number gain | not provided [RCV000748053] | Chr9:10590..141107672 [GRCh37] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh37/hg19 9p24.3-q34.3(chr9:46587-141066491)x3 | copy number gain | not provided [RCV000748063] | Chr9:46587..141066491 [GRCh37] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh37/hg19 9p24.3-q34.3(chr9:10590-141114095)x2 | copy number gain | not provided [RCV000748054] | Chr9:10590..141114095 [GRCh37] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh37/hg19 9q21.11-34.3(chr9:71416475-141020389)x3 | copy number gain | not provided [RCV000847808] | Chr9:71416475..141020389 [GRCh37] Chr9:9q21.11-34.3 |
pathogenic |
GRCh37/hg19 9p24.3-q34.3(chr9:203861-141020388)x3 | copy number gain | not provided [RCV000845900] | Chr9:203861..141020388 [GRCh37] Chr9:9p24.3-q34.3 |
pathogenic |
Database | Acc Id | Source(s) |
AGR Gene | HGNC:7749 | AgrOrtholog |
COSMIC | NEK6 | COSMIC |
Ensembl Genes | ENSG00000119408 | ENTREZGENE, UniProtKB/Swiss-Prot |
Ensembl Protein | ENSP00000319734 | ENTREZGENE, UniProtKB/Swiss-Prot |
ENSP00000362698 | UniProtKB/TrEMBL | |
ENSP00000362702 | ENTREZGENE, UniProtKB/Swiss-Prot | |
ENSP00000362705 | UniProtKB/Swiss-Prot | |
ENSP00000377749 | ENTREZGENE, UniProtKB/Swiss-Prot | |
ENSP00000389517 | UniProtKB/TrEMBL | |
ENSP00000399847 | UniProtKB/TrEMBL | |
ENSP00000403087 | UniProtKB/TrEMBL | |
ENSP00000403414 | UniProtKB/TrEMBL | |
ENSP00000405215 | UniProtKB/TrEMBL | |
ENSP00000411401 | UniProtKB/TrEMBL | |
ENSP00000439651 | ENTREZGENE, UniProtKB/Swiss-Prot | |
ENSP00000441426 | ENTREZGENE, UniProtKB/Swiss-Prot | |
ENSP00000441469 | ENTREZGENE, UniProtKB/Swiss-Prot | |
ENSP00000442636 | ENTREZGENE, UniProtKB/Swiss-Prot | |
Ensembl Transcript | ENST00000320246 | ENTREZGENE, UniProtKB/Swiss-Prot |
ENST00000373596 | UniProtKB/TrEMBL | |
ENST00000373600 | ENTREZGENE, UniProtKB/Swiss-Prot | |
ENST00000373603 | UniProtKB/Swiss-Prot | |
ENST00000394199 | ENTREZGENE, UniProtKB/Swiss-Prot | |
ENST00000422297 | UniProtKB/TrEMBL | |
ENST00000423785 | UniProtKB/TrEMBL | |
ENST00000425237 | UniProtKB/TrEMBL | |
ENST00000444973 | UniProtKB/TrEMBL | |
ENST00000447379 | UniProtKB/TrEMBL | |
ENST00000454453 | UniProtKB/TrEMBL | |
ENST00000539416 | ENTREZGENE, UniProtKB/Swiss-Prot | |
ENST00000540326 | ENTREZGENE, UniProtKB/Swiss-Prot | |
ENST00000545174 | ENTREZGENE, UniProtKB/Swiss-Prot | |
ENST00000546191 | ENTREZGENE, UniProtKB/Swiss-Prot | |
GTEx | ENSG00000119408 | GTEx |
HGNC ID | HGNC:7749 | ENTREZGENE |
Human Proteome Map | NEK6 | Human Proteome Map |
InterPro | Kinase-like_dom_sf | UniProtKB/Swiss-Prot |
Prot_kinase_dom | UniProtKB/Swiss-Prot | |
Protein_kinase_ATP_BS | UniProtKB/Swiss-Prot | |
Ser-Thr/Tyr_kinase_cat_dom | UniProtKB/Swiss-Prot | |
Ser/Thr_kinase_AS | UniProtKB/Swiss-Prot | |
KEGG Report | hsa:10783 | UniProtKB/Swiss-Prot |
NCBI Gene | 10783 | ENTREZGENE |
OMIM | 604884 | OMIM |
Pfam | Pkinase | UniProtKB/Swiss-Prot |
PharmGKB | PA31550 | PharmGKB |
PRINTS | TYRKINASE | UniProtKB/Swiss-Prot |
PROSITE | PROTEIN_KINASE_ATP | UniProtKB/Swiss-Prot |
PROTEIN_KINASE_DOM | UniProtKB/Swiss-Prot | |
PROTEIN_KINASE_ST | UniProtKB/Swiss-Prot | |
SMART | S_TKc | UniProtKB/Swiss-Prot |
Superfamily-SCOP | SSF56112 | UniProtKB/Swiss-Prot |
UniGene | Hs.197071 | ENTREZGENE |
UniProt | A0A024R8A6 | ENTREZGENE, UniProtKB/TrEMBL |
NEK6_HUMAN | UniProtKB/Swiss-Prot | |
Q5TBG1_HUMAN | UniProtKB/TrEMBL | |
Q5TBG2_HUMAN | UniProtKB/TrEMBL | |
Q5TBG4_HUMAN | UniProtKB/TrEMBL | |
Q5TBG7_HUMAN | UniProtKB/TrEMBL | |
Q5TBH0_HUMAN | UniProtKB/TrEMBL | |
Q5TBH1_HUMAN | UniProtKB/TrEMBL | |
Q5TBH2_HUMAN | UniProtKB/TrEMBL | |
Q9HC98 | ENTREZGENE | |
UniProt Secondary | B7Z2D9 | UniProtKB/Swiss-Prot |
Q5TBG3 | UniProtKB/Swiss-Prot | |
Q5TBG9 | UniProtKB/Swiss-Prot | |
Q6FG86 | UniProtKB/Swiss-Prot | |
Q6IAR3 | UniProtKB/Swiss-Prot | |
Q96E83 | UniProtKB/Swiss-Prot | |
Q9ULX2 | UniProtKB/Swiss-Prot |
Date | Current Symbol | Current Name | Previous Symbol | Previous Name | Description | Reference | Status |
---|---|---|---|---|---|---|---|
2016-01-19 | NEK6 | NIMA related kinase 6 | NIMA-related kinase 6 | Symbol and/or name change | 5135510 | APPROVED | |
2012-11-20 | NEK6 | NIMA-related kinase 6 | NIMA (never in mitosis gene a)-related kinase 6 | Symbol and/or name change | 5135510 | APPROVED |
![]() |
More on NEK6 | |
![]() |
Alliance Gene |
![]() |
NCBI Gene |
![]() |
Ensembl Gene |
![]() |
JBrowse: hg19 hg38 |
![]() |
HGNC Report |
![]() |
NCBI Genome Data Viewer |
CRRD Object Information | |
CRRD ID: | 1347059 |
Created: | 2005-03-08 |
Species: | Homo sapiens |
Last Modified: | 2019-11-26 |
Status: | ACTIVE |
![]() |
![]() |
![]() |
![]() |
RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.